Identification and preliminary characterization of ubiquitin C terminal hydrolase 1 (UCHL1) as a biomarker of neuronal loss in aneurysmal subarachnoid hemorrhage

By using two different approaches, ubiquitin C‐terminal hydrolase 1 (UCHL1) was identified as a potential cerebrospinal fluid (CSF) biomarker of neuronal loss in aneurysmal subarachnoid hemorrhage (ASAH) and presumably other CNS damage and disease states. Appropriate antibodies and a sensitive ELISA were generated, and the release of UCHL1 into CSF was compared with that of pNF‐H and S100β in a cohort of 30 ASAH patients. Both UCHL1 and pNF‐H showed persistent release into CSF in almost all patients in the second week postaneurysmal rupture (AR), and S100β levels rapidly declined to baseline levels in 23 of 30 patients. Seven of thirty patients showed persistently elevated S100β levels over the first 5 days post‐AR and also had relatively higher levels of pNF‐H and UCHL1 higher compared with the rest. These patients proved to have very poor outcomes, with 6 of 7 expiring. Patients who did reduce S100β levels tended to have a better outcome if pNF‐H and UCHL1 levels were also lower, and elevated UCHL1 levels in the second week post‐AR were particularly predictive of poor outcome. Acute coordinated releases of large amounts of UCHL1, pNF‐H, and S100β in 16 of 30 patients were observed, suggesting sudden loss of brain tissues associated with secondary events. We conclude that measurement of the CSF levels of these proteins reveals details of ASAH progression and recovery and predicts patient outcome. © 2010 Wiley‐Liss, Inc.

[1]  J. Glass,et al.  Biochemical markers. , 1981, Science.

[2]  H. Hårdemark,et al.  S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. , 1987, Stroke.

[3]  R. Thompson,et al.  Isolation of PGP 9.5, a New Human Neurone‐Specific Protein Detected by High‐Resolution Two‐Dimensional Electrophoresis , 1983, Journal of neurochemistry.

[4]  H. Hidaka,et al.  S-100 protein and calmodulin levels in cerebrospinal fluid after subarachnoid hemorrhage. , 1985, Journal of neurosurgery.

[5]  G. Shaw,et al.  Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain. , 2007, Journal of immunological methods.

[6]  Gerry Shaw,et al.  Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF‐H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF‐H as a potential ALS biomarker , 2009, Journal of neurochemistry.

[7]  Gerry Shaw,et al.  Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. , 2005, Biochemical and biophysical research communications.

[8]  K D Wilkinson,et al.  The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. , 1989, Science.

[9]  W. Feuer,et al.  Phosphorylated neurofilament heavy chain is a marker of neurodegeneration in Leber hereditary optic neuropathy (LHON) , 2008, Molecular vision.

[10]  A. Petzold.  Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss , 2005, Journal of the Neurological Sciences.

[11]  Y. Itoyama,et al.  CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain‐Barré syndrome , 2009, Muscle & nerve.

[12]  P. Kochanek,et al.  Biochemical markers of brain injury: could they be used as diagnostic adjuncts in cases of inflicted traumatic brain injury? , 2004, Child abuse & neglect.

[13]  S. Scheff,et al.  The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury. , 2008, Journal of neurotrauma.

[14]  A. Dhillon,et al.  PGP 9.5—a new marker for vertebrate neurons and neuroendocrine cells , 1983, Brain Research.

[15]  B. Hemmer,et al.  EFNS guidelines on disease‐specific CSF investigations , 2009, European journal of neurology.

[16]  L. Puybasset,et al.  S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage* , 2008, Critical care medicine.

[17]  N. Kitchen,et al.  Axonal pathology in subarachnoid and intracerebral hemorrhage. , 2005, Journal of neurotrauma.

[18]  N. Kitchen,et al.  Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: A pilot study , 2002, Critical care medicine.

[19]  B. Romner,et al.  Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury. , 2003, Restorative neurology and neuroscience.

[20]  T. Kilpatrick,et al.  Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis , 2008, Journal of neuroscience research.

[21]  H. Hårdemark,et al.  S-100 protein in cerebrospinal fluid of patients with subarachnoid haemorrhage: A potential marker of brain damage , 2005, Acta Neurochirurgica.

[22]  G. Shaw,et al.  Detection of Phosphorylated NF-H in the Cerebrospinal Fluid and Blood of Aneurysmal Subarachnoid Hemorrhage Patients , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  E. Thompson,et al.  Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern , 2003, Brain Research Bulletin.